[Sentinel node navigation surgery in uterine cancer]

Area of Science:

• Gynecologic Oncology
• Surgical Pathology
• Nuclear Medicine

Context:

• Sentinel node (SN) biopsy is a developing technique in uterine cancers, particularly endometrial cancer.
• Existing data for cervical cancer SN detection rates (15-100%) and sensitivity (66-100%) are highly variable.
• Research into SN detection for endometrial cancer is in its early stages.

Purpose:

• To review the current status and challenges of sentinel node detection in uterine cancers, focusing on cervical and endometrial cancer.
• To evaluate the efficacy of different detection methods, including isotope and dye tracers.
• To identify areas requiring further clinical investigation.

Summary:

• Sentinel node detection methods for uterine cancers involve either isotope tracers (e.g., technetium-99m-labeled phytic acid) or dye tracers (e.g., isosulfan blue), with isotopes showing higher detection rates.
• Injection techniques for cervical cancer SNs typically involve four cervical sites, while endometrial cancer studies explore uterine body, cervical, and hysteroscopic injections.
• Inconsistent detection and sensitivity rates in current studies, especially for cervical cancer, limit reliable clinical application and highlight the need for more data.

Impact:

• Highlights the preliminary nature of sentinel node research in endometrial cancer.
• Underscores the need for standardized protocols and further clinical trials to improve the reliability of SN detection in uterine cancers.
• Provides a basis for future research directions in optimizing SN biopsy techniques for gynecologic malignancies.